CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
Visual Acuity +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05611073
NCT05611073N/ACompleted
CompareCT.gov

Maximizing Visual Outcomes With Eyhance IOLs

Berkeley Eye Center·observational·Posted Nov 9, 2022·Updated May 23, 2025

In Brief

An observational study evaluating Visual Acuity, Biometric Data Collection, and 1 other intervention for Pseudophakia. Completed, enrolled 110 participants across 1 site.

Detailed Summary

This is a non-interventional prospective, single center, bilateral, non-randomized, open-label, observational clinical study. All patients will have had bilateral implantation of an Eyhance IOL at the time of cataract surgery. These patients will then be compared to assess which patient biometric properties (such as spherical aberration, q value, pupil size, etc.) lead to an overall increase in near or intermediate vision as well as overall patient satisfaction.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPseudophakia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedNov 9, 2022
Enrollment StartMar 7, 2022
Primary CompletionNov 7, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.6 years ago

Interventions

Visual Acuityother

Measurement of distance, intermediate and near visual acuity.

Biometric Data Collectionother

Measurement of biometric data will be obtained from the Zeiss IOL Master 700, Atlas 9000, and the iTrace.

Patient Questionnaireother

Patients will complete a Patient Questionnaire to determine their level of spectacle independence and visual acuity satisfaction.